Using technology to improve skin cancer screening for survivors of blood cell transplants
Technology-Enabled Activation of Skin Cancer Screening for Hematopoietic Cell Transplantation Survivors and their Primary Care Providers
This study is all about helping people who have had a stem cell transplant learn how to check their skin for cancer using their phones, so they can catch any issues early and get the care they need from their doctors.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project ID | NIH-10819220 on NIH RePORTER |
What this research studies
This research focuses on improving skin cancer screening for survivors of hematopoietic cell transplantation (HCT) by leveraging technology. It aims to equip these survivors with the skills to perform effective skin self-examinations and engage their primary care providers in proactive skin cancer screening. The study will utilize cell phones and teledermoscopy to facilitate remote assessments of skin lesions, ensuring timely access to dermatologic care. By addressing the unique risks faced by HCT survivors, the research seeks to enhance early detection and treatment of skin cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have undergone hematopoietic cell transplantation and are at increased risk for skin cancer.
Not a fit: Patients who have not undergone hematopoietic cell transplantation or do not have a history of skin cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of skin cancers in HCT survivors, ultimately improving their health outcomes.
How similar studies have performed: Other research has shown promise in using technology for cancer screening, indicating that this approach could be effective for HCT survivors as well.
Where this research is happening
Duarte, United States
- Beckman Research Institute/city of Hope — Duarte, United States (Active)
Researchers
- Principal investigator: Armenian, Saro — Beckman Research Institute/city of Hope
- Study coordinator: Armenian, Saro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.